Skip to main content
Quick answer

Both contain the same active ingredient (tirzepatide), but Mounjaro is approved for type 2 diabetes and Zepbound is approved for obesity; formal indications and dosing differ.

Note: This answer is for educational purposes and does not replace a consultation with a specialist who examines your case in person. Do not use it for self-diagnosis.